Drug or chemical induced diabetes mellitus with neurological complications
ICD-10 E09.4 is a billable code used to indicate a diagnosis of drug or chemical induced diabetes mellitus with neurological complications.
Drug or chemical induced diabetes mellitus is a form of diabetes that arises due to the administration of certain medications or exposure to specific chemicals. This condition can lead to various complications, particularly neurological issues, which may manifest as neuropathy, cognitive dysfunction, or other central nervous system disturbances. The pathophysiology involves the disruption of insulin signaling pathways or direct pancreatic damage, leading to hyperglycemia. Patients may present with elevated HbA1c levels, indicating poor glycemic control over the preceding months. Management often includes insulin therapy or oral hypoglycemic agents, depending on the severity of the condition and the patient's overall health. Neurological complications can significantly impact the patient's quality of life and require careful monitoring and intervention. It is crucial for healthcare providers to document the specific drug or chemical responsible for the diabetes, as this information is essential for accurate coding and treatment planning.
Detailed medication history, HbA1c levels, and neurological assessment.
Patients presenting with new-onset diabetes after starting corticosteroids or antipsychotics.
Endocrinologists must ensure that the cause of diabetes is clearly linked to the medication.
Neurological examination findings and correlation with diabetes management.
Patients with diabetic neuropathy or cognitive changes related to diabetes.
Neurologists should document the impact of diabetes on neurological function.
Used to monitor glycemic control in patients with drug-induced diabetes.
Document the date of the test and results.
Endocrinologists should correlate A1c levels with medication adjustments.
Common drugs include corticosteroids, certain antipsychotics, and some chemotherapeutic agents. Each can affect insulin sensitivity or secretion.
